United Kingdom· GB-APID-41965111000001104
Glecaprevir 100mg / Pibrentasvir 40mg tablets
A glecaprevir and pibrentasvir product containing glecaprevir + pibrentasvir, registered in United Kingdom by AbbVie Ltd. The same ATC class is registered in 15 of our 19 countries.
Checked against NHS dm+d (United Kingdom) on
Informational only — not a medical device.
Where it is registered
Glecaprevir and pibrentasvir is registered in 15 of 19 countries.
Countries holding a registration under ATC J05AP57 (glecaprevir and pibrentasvir), each read from that country’s own register.
- This record: United Kingdom, from NHS dm+d (United Kingdom)
- 10 of them publish a price we can compare per daily dose
Glecaprevir and pibrentasvir · ATC J05AP57
15 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Ireland
- Italyprice
- Netherlands
- Norwayprice
- Polandprice
- Spainprice
- Switzerlandprice
- United Kingdom
- United Statesprice
The record
At a glance
NHS dm+d (United Kingdom)- Active substance
- Glecaprevir + Pibrentasvir
- Manufacturer
- AbbVie Ltd
- Country
- United Kingdom (GB)
- ATC code
- J05AP57
- ATC class
- Glecaprevir and pibrentasvir
- Reimbursed
- Not published by this register
- Source register
- NHS dm+d (United Kingdom)
- Last checked
- September 13, 2026
Packs & prices · 1
- gtin08054083018973
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Glecaprevir and pibrentasvir in 13 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United StatesMavyretAbbVie Inc.
- SpainMAVIRET 100 MG/40 MG COMPRIMIDOS RECUBIERTOS CON PELICULAAbbvie Deutschland Gmbh & Co. Kg
- FinlandMaviretAbbVie Deutschland GmbH&Co.KG
- FranceMAVIRET 100 mg/40 mg, comprimé pelliculéABBVIE DEUTSCHLAND (ALLEMAGNE)
- CanadaMAVIRETABBVIE CORPORATION
- IcelandMaviretAbbVie Deutschland GmbH & Co. KG
- NetherlandsMaviret 100 mg/40 mg filmomhulde tablettenAbbVie Deutschland GmbH & Co. KG
- NorwayMaviretAbbVie Deutschland GmbH & Co
Authorised across Europe · EMA
The same active substance is authorised in 3 EEA countries. Names it is sold under:
- Iceland · Maviret
- Liechtenstein · Maviret
- Norway · Maviret
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of NHS dm+d (United Kingdom). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/5c9daf15-4403-4514-a262-4028a291e80a GET /v1/drugs/5c9daf15-4403-4514-a262-4028a291e80a?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"apid": "41965111000001104",
"desc": "Glecaprevir 100mg / Pibrentasvir 40mg tablets (AbbVie Ltd)",
"form": "Oral tablet",
"vpid": "34734811000001103",
"source": "dmd",
"vtm_id": "776104004",
"strength": "100 mg",
"substance": "Glecaprevir + Pibrentasvir",
"ingredient": "Glecaprevir",
"supplier_code": "20741511000001103"
}See everything about glecaprevir and pibrentasvir.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.